Anavex Life Sciences Corp (AVXL)

[stealthways]

The last time I heard him discuss this subject he said something like...usually companies need partners to distribute drugs like 273.... I took this to mean avxl will not really be looking for a partner until after phase 3 .....and I agree that at that point a partner might get 5%ish of revenues for funding manufacturing and distribution .... instead of a partnership before a phase 3 trials which take a big wack of the revenues typically....
I hope they can do a side deal with the MTA partner on MS alone though... With a new president running their company I doubt they are able to make the extra large investment that would be required to take over all indications. That is understandable IMO .... a new president , in most companies, typically acts pretty conservative with funds but is aggressive in strategy.... Except for the MS indication, its likely MUCH MUCH better to continue on alone with planned trials IMO....